• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 SAFESTEP HUBER NEEDLE SET 20G X 0.75IN; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 SAFESTEP HUBER NEEDLE SET 20G X 0.75IN; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Model Number N/A
Device Problem Activation Problem (4042)
Patient Problems Exposure to Body Fluids (1745); Needle Stick/Puncture (2462)
Event Date 11/08/2022
Event Type  Injury  
Manufacturer Narrative
The date of event was not provided by the complainant/reporter, the date reflected in this report is the date bd became aware of the event.The device has not been returned to the manufacturer for evaluation.A lot history review (lhr) of asfyf070 showed no other similar product complaint(s) from this lot number.
 
Event Description
It was reported on removal, the retraction system did not fully deploy causing the nurse to be pricked.
 
Manufacturer Narrative
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : device not returned.
 
Event Description
It was reported on removal, the retraction system did not fully deploy causing the nurse to be pricked.Additional information: the event occurred after removing a needle from the patient.The affected nurse required labs/monitoring but no prophylactic or therapeutic treatment.The affected nurse has recovered.The patient on whom the needle was used did not have blood borne diseases.
 
Manufacturer Narrative
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The following were reviewed as part of this investigation: patient severity, applicable previous investigation(s), sample (if available), complaint and lot history review, and applicable fmea documents.Based on a review of this information, the following was concluded: the complaint of difficulty activating a safety mechanism is inconclusive due to the state of the returned sample.One 20 g x 0.75 in.Safestep infusion set was returned for evaluation.An initial visual observation showed a small amount of use residue on the returned sample.The safety mechanism of the returned device was found to be engaged over the needle tip.No bends were found in the needle shaft, and a microscopic observation revealed the needle tip was undamaged.The safety mechanism was able to be deactivated and reactivated without any notable resistance.While no damage, defect, or other issue could be found on the safety mechanism of the returned sample, environmental conditions, buildup of residue on the device, and/or de-accessing technique could have contributed to the reported difficulty activating the safety mechanism.H3 other text : evaluation findings are in section h.11.
 
Event Description
It was reported on removal, the retraction system did not fully deploy causing the nurse to be pricked.Additional information: the event occurred after removing a needle from the patient.The affected nurse required labs/monitoring but no prophylactic or therapeutic treatment.The affected nurse has recovered.The patient on whom the needle was used did not have blood borne diseases.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SAFESTEP HUBER NEEDLE SET 20G X 0.75IN
Type of Device
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer Contact
becky garcia
605 north 5600 west
salt lake city 84116
8015950700
MDR Report Key15835169
MDR Text Key304027463
Report Number3006260740-2022-05410
Device Sequence Number1
Product Code FPA
UDI-Device Identifier00801741066207
UDI-Public(01)00801741066207
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K153440
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 02/03/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberN/A
Device Catalogue NumberLH-0031
Device Lot NumberASFYF070
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/08/2022
Initial Date FDA Received11/21/2022
Supplement Dates Manufacturer Received11/21/2022
02/03/2023
Supplement Dates FDA Received12/02/2022
02/08/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/01/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-